This cross-sectional study of a large pragmatic population-based screening trial evaluating a cell-free DNA–based multicancer early detection test reveals potential unintended consequences of downstream work-ups log-jamming healthcare systems, delaying care for those with real clinical needs outside an investigational lab result. | Mann, JAMA 2026
